The European Multidisciplinary Cancer Congress | Conference

The 2011 European Multidisciplinary Cancer Congress Slideshow

September 27th 2011

Pictures from The 2011 European Multidisciplinary Cancer Congress (EMCC) in Stockholm, Sweden

Synchronous Radiotherapy With Chemotherapy Improves Local Control in Early Breast Cancer Patients

September 26th 2011

Radiotherapy can be given between or during chemotherapy cycles, rather than sequentially, for women with early breast cancer.

Synchronous Radiotherapy With Chemotherapy Improves Local Control in Early Breast Cancer Patients

September 26th 2011

Radiotherapy can be given between or during chemotherapy cycles, rather than sequentially for women with early breast cancer.

Aflibercept Improves Survival in Metastatic Colorectal Cancer Patients

September 26th 2011

Aflibercept added to FOLFIRI chemotherapy improved PFS and OS in previously treated patients with metastatic colorectal cancer.

T-DM1 Achieves Longer Progression-Free Survival vs. Standard Therapy in HER2+ Metastatic Breast Cancer

September 25th 2011

T-DM1 extended progression-free survival by 40% in HER2+ metastatic breast cancer and was less toxic, compared with standard therapy.

Panitumumab Extends Progression-Free Survival in HPV-Negative Subset of Advanced Head and Neck Cancer

September 25th 2011

Panitumumab + chemo improves OS and PFS in patients with metastatic carcinoma of the head and neck that were negative for HPV.

Survival Benefit Shown With Investigational Alpha-Emitting Radiopharmaceutical in Men With Hormone Resistant Metastatic Prostate Cancer

September 24th 2011

Investigational drug that emits alpha radiation shows significant improvement in overall survival.

Novel Infusion Approach Significantly Delays Progression in Uveal Melanoma Patients With Liver Metastases

September 24th 2011

Patients with liver metastases from uveal melanoma had improved survival after treatment with percutaneous hepatic perfusion (PHP).

Two Predictors of Prostate Cancer Explored in Healthy Men

September 23rd 2011

Two studies enhance understanding of risk factors for prostate cancer.

Image of Stockholm City Hall

September 23rd 2011

The 16th ECCO, 36th ESMO, 30th ESTRO Congresses from the 2011 European Multidisciplinary Cancer Congress in Stockholm, Sweden, September 23-27.